NeoGenomics Inc (NEO)

Industry Diagnostics & Research

This stock can be held in an Investment ISA and an Investment Account

Sell

$11.74

Buy

$12.09

arrow-up$0.08 (+0.68%)

Prices updated at 12 Dec 2025, 23:53 EST

Prices minimum 15 mins delay

Prices in USD

NeoGenomics Inc operates a network of cancer-related testing laboratories in Ft. Myers and Tampa, Florida, Irvine, California and Nashville, and Tennessee.

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Diagnostics & Research

Chairman

Ms. Lynn A. Tetrault, J.D.

CEO

Mr. Anthony P. Zook

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

2,200

Head office

9490 NeoGenomics Way

Fort Myers

United States

33912

+1 239 768-0600

bill.bonello@neogenomics.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Anthony P. Zook Director and Chief Executive Officer	0.08m
Mr. Warren C. Stone President and Chief Operating Officer	0.56m
Ms. Beth Eastland Senior Vice President, Enterprise Sales	-
Ms. Marjorie C. Green Independent Director	-
Mr. Jeffrey S. Sherman Chief Financial Officer	0.54m
Ms. Lynn A. Tetrault, J.D. Chairman of the Board	0.13m
Mr. Michael A. Kelly Independent Director	0.08m
Dr. Alison L. Hannah, M.D. Independent Director	0.07m
Mr. Gregory D. Aunan Chief Accounting Officer and Senior Vice President	-
Mr. Stephen M. Kanovsky Independent Director	0.07m
Mr. David B. Perez Independent Director	0.07m
Ms. Alicia C. Olivo Executive Vice President, Business Development, General Counsel and Corporate Secretary	0.51m
Dr. Neil Gunn Independent Director	0.07m
Ms. Felicia Williams Independent Director	-
Ms. Cynthia J. Dieter Chief Accounting Officer and Controller	-

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
BlackRock Inc	19,298,929
Vanguard Group Inc	14,130,761
BlackRock Fund Advisors	13,767,287
First Light Asset Management, LLC	9,927,269
Greenhouse Funds LLLP	8,220,657

Director dealings

Date chevron-l-regular chevron-r-regular	Action
07 Dec 2024	-
01 Dec 2024	-
15 Nov 2024	-
01 Sep 2024	-
15 Aug 2024	-
10 Aug 2024	-
10 Aug 2024	-
10 Aug 2024	-
10 Aug 2024	-
10 Aug 2024	-
10 Aug 2024	-
10 Aug 2024	-
10 Aug 2024	-
10 Aug 2024	-
10 Aug 2024	-
10 Aug 2024	-
10 Aug 2024	-
10 Aug 2024	-
10 Aug 2024	-
10 Aug 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.